BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36330068)

  • 1. Characteristic analysis of clinical trials for new traditional Chinese medicines in mainland China from 2013 to 2021.
    Zhou Y; Yang J; He Y; Lv Y; Wang C; Deng H; Huang J
    Front Med (Lausanne); 2022; 9():1008683. PubMed ID: 36330068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Registration of intervention trials of Traditional Chinese Medicine for four neurological diseases on Chinese Clinical Trial Registry and ClinicalTrials.gov: a narrative review.
    Wei JJ; Guo RJ; Fu GJ; Liang X; Xu ZM; Jia M; Zeng ZX; Du WQ; Jiao WW; Sun LJ; Liu HM; Guo CL; Tong CG; Zhang YL; Liao X
    J Tradit Chin Med; 2022 Feb; 42(1):148-153. PubMed ID: 35294135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of ischemic stroke drug clinical trials in mainland China from 2005 to 2021.
    Bo C; Wang T; Hou C; Han J; Chen L; Zhang H; Wang L; Li H
    CNS Neurosci Ther; 2022 Aug; 28(8):1229-1239. PubMed ID: 35642775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cross-sectional study on the application of patient-reported outcome measurements in clinical trials of traditional Chinese medicine in mainland China.
    Dong Y; Liu L; Zhang X; Gong Y; Yan S; Li W; Li S; Rong H; Liu J
    Front Pharmacol; 2023; 14():1159906. PubMed ID: 37251323
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial.
    Zeng C; Yuan Z; Pan X; Zhang J; Zhu J; Zhou F; Shan Z; Yuan Y; Ye R; Cheng J
    Trials; 2020 Dec; 21(1):1029. PubMed ID: 33357239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The reporting quality, scientific rigor, and ethics of randomized placebo-controlled trials of traditional Chinese medicine compound formulations and the differences between Chinese and non-Chinese trials.
    Zhong YQ; Fu JJ; Liu XM; Diao X; Mao B; Fan T; Yang HM; Liu GJ; Zhang WB
    Curr Ther Res Clin Exp; 2010 Feb; 71(1):30-49. PubMed ID: 24683249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis on clinical study protocols of traditional Chinese medicine for coronavirus disease 2019].
    Wang H; Jin XY; Pang B; Liu CX; Zheng WK; Yang FW; Pang WT; Zhang JH
    Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1232-1241. PubMed ID: 32281330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of Lian-Ju-Gan-Mao capsules for treating the common cold with wind-heat syndrome: study protocol for a randomized controlled trial.
    Wang S; Jiang H; Yu Q; She B; Mao B
    Trials; 2017 Jan; 18(1):2. PubMed ID: 28057058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applying regulatory science in traditional chinese medicines for improving public safety and facilitating innovation in China: a scoping review and regulatory implications.
    Liang Z; Lai Y; Li M; Shi J; Lei CI; Hu H; Ung COL
    Chin Med; 2021 Feb; 16(1):23. PubMed ID: 33593397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of clinical trial of new drugs of traditional Chinese medicines].
    Yang ZQ; Tang YQ; DU YP; Tang HM; Zhang L; Gao R; Hu SY; Tang JY; Yuan WA
    Zhongguo Zhong Yao Za Zhi; 2021 Apr; 46(7):1691-1695. PubMed ID: 33982470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The changing landscape of anti-lymphoma drug clinical trials in mainland China in the past 15 years (2005-2020): A systematic review.
    Chen H; Zhou Y; Han X; Shi Y
    Lancet Reg Health West Pac; 2021 Mar; 8():100097. PubMed ID: 34327425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compound Formulas of Traditional Chinese Medicine for the Common Cold: Systematic Review of Randomized, Placebo-controlled Trials.
    Li G; Cai L; Jiang H; Dong S; Fan T; Liu W; Xie L; Mao B
    Altern Ther Health Med; 2015; 21(6):48-57. PubMed ID: 26567449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
    Li S; Li JP
    Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends of Phase I Clinical Trials of New Drugs in Mainland China Over the Past 10 Years (2011-2020).
    Chen C; Lou N; Zheng X; Wang S; Chen H; Han X
    Front Med (Lausanne); 2021; 8():777698. PubMed ID: 34977078
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis on oral medication rules of traditional Chinese medicine prescriptions for prevention of COVID-19.
    Wu DY; Hou XT; Xia ZS; Hao EW; Xie JL; Liang JY; Liang QM; Du ZC; Deng JG
    Chin Herb Med; 2021 Oct; 13(4):502-517. PubMed ID: 34659385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of Ding-Kun-Dan for female infertility patients with predicted poor ovarian response undergoing in vitro fertilization/intracytoplasmic sperm injection: study protocol for a randomized controlled trial.
    Ma S; Ma R; Xia T; Afnan M; Song X; Xu F; Hao G; Zhu F; Han J; Zhao Z
    Trials; 2018 Feb; 19(1):124. PubMed ID: 29458401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The changing landscape of anti-lung cancer drug clinical trials in mainland China from 2005 to 2020.
    Zhong Q; Tao Y; Chen H; Zhou Y; Huang L; Han X; Shi Y
    Lancet Reg Health West Pac; 2021 Jun; 11():100151. PubMed ID: 34327360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trend of drug clinical trials in mainland China from 2009 to 2020.
    Cao Y; Liao L; Liu X; Zheng Q; Xu Z; Niu H
    Curr Med Res Opin; 2022 Sep; 38(9):1499-1507. PubMed ID: 35855662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bidirectional effects and mechanisms of traditional Chinese medicine.
    Peng X; Tang F; Yang Y; Li T; Hu X; Li S; Wu W; He K
    J Ethnopharmacol; 2022 Nov; 298():115578. PubMed ID: 35917892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.